Medical Condition News

RSS

Immune Pharmaceuticals begins bertilimumab Phase II clinical trials in Bullous Pemphigoid, Ulcerative Colitis

Immune Pharmaceuticals Inc. announced today that it has initiated its Phase II Ulcerative Colitis clinical trial and is scheduled to initiate its Phase II Bullous Pemphigoid clinical trial on July 1, 2015. Study Initiation is the training of hospital staff to allow for patient screening and immediate patient enrollment into the clinical trial upon selection.

25 Jun 2015

Cognitive behavioural therapy can change brain function of people with Tourette syndrome

In addition to its effect on chronic tics, cognitive behavioural therapy (CBT) can change the brain function of people with Tourette syndrome.

25 Jun 2015

UAlberta partnership could transform cancer treatment, improve patient outcomes

A multimillion dollar research partnership announced today at the University of Alberta is giving a "dream team" of researchers the opportunity to potentially transform cancer treatment and better patient outcomes.

25 Jun 2015

New 3D cell culture system could facilitate search for therapeutic agents for Parkinson's disease

The progressive loss of neurons in the brain of Parkinson's patients is slow yet inexorable. So far, there are no drugs that can halt this insidious process.

25 Jun 2015

Weight loss along with vitamin D supplementation reduces chronic inflammation

For the first time, researchers at Fred Hutchinson Cancer Research Center have found that weight loss, in combination with vitamin D supplementation, has a greater effect on reducing chronic inflammation than weight loss alone.

25 Jun 2015

Detroit-area patients contribute to national study that redefines diagnosis, treatment of glioma

Sixty-seven patients from the Hermelin Brain Tumor Center at Henry Ford Hospital and their families made important contributions to a national cancer study that proposes a change in how some brain tumors are classified - and ultimately treated.

25 Jun 2015

Uninterrupted NOAC treatment during catheter ablation of atrial fibrillation is safe, shows research

Uninterrupted treatment with novel oral anticoagulants (NOACs) during catheter ablation of atrial fibrillation (AF) is safe, reveals research presented today at EHRA EUROPACE - CARDIOSTIM 2015 by Dr Carsten Wunderlich, senior consultant in the Department of Invasive Electrophysiology, Heart Centre Dresden, Germany.

25 Jun 2015

Researchers emphasize need to define normal and abnormal emotions

We all feel emotion, we all get upset, can feel low, angry and overjoyed, but when do these emotional responses become something of a medical concern?

25 Jun 2015

Novo Nordisk presents new data detailing the impact of hemophilia on patients, caregivers

Today, Novo Nordisk presented new data detailing the impact hemophilia has on both caregivers and those living with the disease.

From Novo Nordisk 25 Jun 2015

STAR tumor ablation system reduces pain from spinal tumors, improves quality of life

Many patients with advanced cancers experience significant pain, and the pain caused by metastases (cancers that have spread to the spine) can be excruciating as tumor growth replaces bone.

25 Jun 2015

Neuromodulator norepinephrine has direct action on auditory processing of complex signals

For neuroscientists studying the intricate mechanisms of hearing in the brain's auditory cortex, a major question has been how a listener can focus in a noisy environment, and how neurochemicals help neurons convey as much embedded information as possible for the rest of the brain to act on.

25 Jun 2015

Researchers determine underlying barriers to carrying out effective clinical trials in Parkinson's disease

Despite an urgent need for new medications, clinical trials in Parkinson's disease (PD) have a relatively low rate of success.

25 Jun 2015

Researchers advance stem cell therapy to block vision loss caused by diabetic retinopathy

University of Virginia School of Medicine researchers have taken a significant step forward in their efforts to use stem cells to block vision loss caused by diabetic retinopathy, a condition that affects millions of people with diabetes.

25 Jun 2015

Noisy road traffic may reduce life expectancy, increase stroke risk

Living in an area with noisy road traffic may reduce life expectancy, according to new research published in the European Heart Journal.

25 Jun 2015

Innovative formula prevents risks, painful treatments in people with secondary blindness

The Mexican company "Medical and Surgical Center for Retina" created a way to transport drugs, in order to avoid risks and painful treatments in people with secondary blindness due to chronic degenerative blindness such as diabetic retinopathy and degeneration of the eye.

25 Jun 2015

Myriad Genetics, Chris4Life launch educational campaign to teach individuals about risk of hereditary cancer

Chris4Life Colon Cancer Foundation, a Washington, D.C.-based national non-profit organization, and Myriad Genetics, a leader in personalized medicine, today announced their “What’s Your History” family history week (June 24-30, 2015).

25 Jun 2015

Sugar-gobbling enzyme helps restore normal function in heart muscles of diabetic rats

Working with heart muscle cells from diabetic rats, scientists at Johns Hopkins have located what they say is the epicenter of mischief wreaked by too much blood sugar and used a sugar-gobbling enzyme to restore normal function in the glucose-damaged cells of animal heart muscles.

25 Jun 2015

Emperra’s ESYSTA® diabetes smartphone app, ESYSTA® Smart Insulin Pen under CE conformity assessment procedure

Emperra GmbH E-Health Technologies, specialized in digital health systems and Tele-diabetology, today announced an important further development of the innovative, integrated telemonitoring product system ESYSTA for insulin-dependent diabetes patients.

25 Jun 2015

Study shows cystic fibrosis is more deadly for Hispanic than non-Hispanic patients

Cystic fibrosis is more deadly for Hispanic than non-Hispanic patients, a disparity that is not explained by differences in their access to health care, according to a new study from the Stanford University School of Medicine.

25 Jun 2015

Scripps Florida scientists receive $3.5 million to accelerate development of anti-diabetic compounds

Scientists from the Florida campus of The Scripps Research Institute (TSRI) have been awarded $3.5 million from the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health to accelerate development of a new class of anti-diabetic compounds.

25 Jun 2015

Medical Condition News

Immune Pharmaceuticals begins bertilimumab Phase II clinical trials in Bullous Pemphigoid, Ulcerative Colitis

Cognitive behavioural therapy can change brain function of people with Tourette syndrome

UAlberta partnership could transform cancer treatment, improve patient outcomes

New 3D cell culture system could facilitate search for therapeutic agents for Parkinson's disease

Weight loss along with vitamin D supplementation reduces chronic inflammation

Detroit-area patients contribute to national study that redefines diagnosis, treatment of glioma

Uninterrupted NOAC treatment during catheter ablation of atrial fibrillation is safe, shows research

Researchers emphasize need to define normal and abnormal emotions

Novo Nordisk presents new data detailing the impact of hemophilia on patients, caregivers

STAR tumor ablation system reduces pain from spinal tumors, improves quality of life

Neuromodulator norepinephrine has direct action on auditory processing of complex signals

Researchers determine underlying barriers to carrying out effective clinical trials in Parkinson's disease

Researchers advance stem cell therapy to block vision loss caused by diabetic retinopathy

Noisy road traffic may reduce life expectancy, increase stroke risk

Innovative formula prevents risks, painful treatments in people with secondary blindness

Myriad Genetics, Chris4Life launch educational campaign to teach individuals about risk of hereditary cancer

Sugar-gobbling enzyme helps restore normal function in heart muscles of diabetic rats

Emperra’s ESYSTA® diabetes smartphone app, ESYSTA® Smart Insulin Pen under CE conformity assessment procedure

Study shows cystic fibrosis is more deadly for Hispanic than non-Hispanic patients

Scripps Florida scientists receive $3.5 million to accelerate development of anti-diabetic compounds

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News